Prediction of endometriosis with serum and peritoneal fluid markers: a prospective controlled trial
article
OA: bronze
CC0
⤵ 347 in-corpus citations
AI-generated summary
Serum IL-6 and peritoneal fluid TNF-alpha concentrations discriminated between women with and without endometriosis with high sensitivity and specificity.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
BACKGROUND: The objective of this prospective controlled trial was to investigate the ability of a group of serum and peritoneal fluid (PF) markers to predict, non-surgically, endometriosis. METHODS AND RESULTS: Serum and PF samples were obtained from 130 women while undergoing laparoscopy for pain, infertility, tubal ligation or sterilization reversal. Concentrations of six cytokines [interleukin (IL)-1beta, IL-6, IL-8, IL-12, IL-13 and tumour necrosis factor (TNF)-alpha] were measured in serum and PF, and reactive oxygen species (ROS) in PF, and levels were compared among women who were allocated to groups according to their post-surgical diagnosis. Fifty-six patients were diagnosed with endometriosis, eight with idiopathic infertility, 27 underwent tubal ligation or reanastomosis (control group) and 39 were excluded due to bloody PF. Only serum IL-6 and PF TNF-alpha could be used to discriminate between patients with and without endometriosis with a high degree of sensitivity and specificity (P < 0.001). A threshold of 15 pg/ml PF TNF-alpha provided 100% sensitivity and 89% specificity (positive likelihood ratio of 9.1 and negative likelihood ratio of 0). A threshold of 2 pg/ml for serum IL-6 provided a sensitivity of 90% and specificity of 67% (positive likelihood ratio of 2.7 and negative likelihood ratio of 0.14). CONCLUSIONS: By measuring serum IL-6 and PF TNF-alpha, it was possible to discriminate between patients with endometriosis and those without. Before these markers can be used as a non-surgical diagnostic tool, these data should be verified in a larger study.
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (37)
- Basal and stimulated secretion of cytokines by peritoneal macrophages in women with endometriosis via openalex
- Characterization of leukocyte subpopulations in the peritoneal fluid of women with endometriosis via openalex
- Comparison of cytokine levels and embryo toxicity in peritoneal fluid in infertile women with untreated or treated endometriosis via openalex
- Correction to “Eisermann J, Gast MJ, Pineda J, Odem RR, Collins JL: Tumor necrosis factor in peritoneal fluid of women undergoing laparoscopic surgery. Fertil Steril 50:573, 1988” via openalex
- Current concepts in endometriosis. via openalex
- Current Concepts of Endometriosis via openalex
- Decreased levels of the potent regulator of monocyte/macrophage activation, interleukin-13, in the peritoneal fluid of patients with endometriosis via openalex
- Endocrinology and paracrinology via openalex
- Endometriosis: Secretion of interleukin-6 by human endometriotic cells and regulation by proinflammatory cytokines and sex steroids via openalex
- Endometriotic disease: the role of peritoneal fluid via openalex
- IL‐1β TNF‐α, and IL‐2 in Peritoneal Fluid and Macrophage‐Conditioned Media of Women With Endometriosis via openalex
- Importance portance of reactive oxygen species in the peritoneal fluid of women with endometriosis or idiopathic infertility via openalex
- Increased concentrations of soluble tumour necrosis factor receptor (sTNFR) I and II in peritoneal fluid from women with endometriosis via openalex
- Increased levels of interleukin-6 and interleukin-10 in the peritoneal fluid of patients with endometriosis via openalex
- Interleukin-6 secretion in vitro is up-regulated in ectopic and eutopic endometrial stromal cells from women with endometriosis via openalex
- Interleukin-6 secretion in vitro is up-regulated in ectopic and eutopic endometrial stromal cells from women with endometriosis. via openalex
- Peritoneal fluid concentrations of interleukin-8 in women with endometriosis: relationship to stage of disease via openalex
- Peritoneal fluid cytokines and the relationship with endometriosis and pain via openalex
- Peritoneal Fluid lnterleukin‐1β and Tumor Necrosis Factor in Patients With Benign Gynecologic Disease via openalex
- Peritoneal interleukin-10 increases with decrease in activated CD4+ T lymphocytes in women with endometriosis via openalex
- Release of tumor necrosis factor-α by human peritoneal macrophages in vivo and in vitro via openalex
- Revised American Society for Reproductive Medicine classification of endometriosis: 1996 via openalex
- The Peritoneal Fluid Levels of Interleukin‐12 in Women with Endometriosis via openalex
- Tumor Necrosis Factor in Plasma and Peritoneal Fluid of Women with and without Endometriosis via openalex
- Tumor necrosis factor-α but not interleukin-1β or interleukin-8 concentrations correlate with angiogenic activity of peritoneal fluid from patients with minimal to mild endometriosis via openalex
- Tumour necrosis factor α concentrations in the peritoneal fluid of infertile women with minimal or mild endometriosis are lower in patients with red lesions only than in patients without red lesions via openalex
- W2069753865 via openalex
- W2193981851 via openalex
- W2051978298 via openalex
- W2412739212 via openalex
- W2042642675 via openalex
- W2003471941 via openalex
- W4243890652 via openalex
- W2142285406 via openalex
- W4255880449 via openalex
- W2137772824 via openalex
- W2107668882 via openalex
Cited by (50)
- Impact of dietary patterns on pain and quality of life in ovarian and deep endometriosis: observational study for nutritional interventions 2025
- Quantification of Protein Biomarkers in SonoPODography Fluid Using Single Molecule Arrays for Endometriosis 2025
- Evaluation of Proinflammatory Cytokines Concentrations in Plasma, Peritoneal, and Endometrioma Fluids in Women Operated on for Ovarian Endometriosis—A Pilot Study 2025
- Therapeutic effects and mechanisms of alcohol extracts from Polygala fallax Hemsl on endometriosis in rats 2025
- Burrowing behavior is a potential non-invasive proxy for lesion development in a syngeneic murine model of endometriosis 2025
- Fertility preservation in women with endometriosis 2025
- Biomarkers of endometriosis 2025
- Broadening horizons: microbiota as a novel biomarker and potential treatment for endometriosis 2025
- Endometriosis as an immune-mediated disease: pathogenetic mechanisms and therapeutic strategies 2025
- A Preliminary Investigation of the Roles of Endometrial Cells in Endometriosis Development via In Vitro and In Vivo Analyses 2024
- Network-based pharmacology and experimental validation to explore the mechanism of action of the Jiawei Pentongling formula for the treatment of endometriosis-related pain. 2024
- Neutrophil to lymphocytes ratio in deep infiltrating endometriosis as a new toll for clinical management 2024
- Neuroimmunology of Endometriosis-Associated Pain and Its Psychological Aspects 2024
- Nutrition in the Prevention and Treatment of Endometriosis 2024
- Pain Management for Women with Endometriosis 2024
- Pregnancy with endometriosis: Assessment of national-level trends, characteristics, and maternal morbidity at delivery 2024
- Cardiovascular Implications of Gynecological Disorders: Bridging the Gap Between Gynecology and Cardiology 2024
- Determination of cytokines for assessment of inflammatory status at genital endometriosis 2024
- Effect of Fetuin-A and oxidative stress on the occurrence of unexplained infertility 2023
- Modulation of the Proliferative Pathway, Neuroinflammation and Pain in Endometriosis 2023
- Understanding endometriosis from an immunomicroenvironmental perspective 2023
- TNFα-Induced Altered miRNA Expression Links to NF-κB Signaling Pathway in Endometriosis 2023
- The Pathological Role of miRNAs in Endometriosis 2023
- The Impact of Endometriosis on Intracellular Calcium Levels, Cyclic Dependent Kinase 1 (Cdk1) Expression, and Cyclin B Expression in Post-Ovulation Oocytes of Mice Model 2023
- A cohort study on IVF outcomes in infertile endometriosis patients: the effects of rapamycin treatment 2023
- Donor Mesenchymal Stem Cells Program Bone Marrow, Altering Macrophages, and Suppressing Endometriosis in Mice 2023
- Quantification of Interleukins in the Serum: A Non-invasive markers of Endometriosis 2023
- The Role of Dietary Fats in the Development and Treatment of Endometriosis 2023
- Impact of moderate-to-severe endometriosis on IVF cumulative live birth rate: a retrospective matched cohort study 2023
- The Role of Peritoneal Immunity in Peritoneal Endometriosis and Related Infertility 2023
- Cannabis and Endometriosis: The Roles of the Gut Microbiota and the Endocannabinoid System 2023
- Association between endometriosis and risk of type 2 diabetes: Results from the prospective E3N cohort 2023
- Cannabidiol as a potential novel treatment for endometriosis by its anti-inflammatory, antioxidative and antiangiogenic effects in an experimental rat model 2023
- Elevated phosphorylation of estrogen receptor α at serine-118 in ovarian endometrioma 2022
- Impact of curcumin, quercetin, or resveratrol on the pathophysiology of endometriosis: A systematic review 2022
- The role of some inflammatory markers, cytokins and tumor markers in diagnosis of endometriosis 2022
- Association Between Endometriosis and Subsequent Risk of Sjögren’s Syndrome: A Nationwide Population-Based Cohort Study 2022
- Glycemic Index, Glycemic Load, Fiber, and Gluten Intake and Risk of Laparoscopically Confirmed Endometriosis in Premenopausal Women 2022
- Pregnancy outcomes among women with endometriosis and fibroids: registry linkage study in Massachusetts 2022
- Molecular and Biochemical Mechanism of Cannabidiol in the Management of the Inflammatory and Oxidative Processes Associated with Endometriosis 2022
- Serum kisspeptin levels in deep-infiltrating, ovarian, and superficial endometriosis: A prospective observational study 2022
- Effects of metformin, letrozole and atorvastatin on inflammation and apoptosis in experimental peritoneal and ovarian endometriosis in the rat 2022
- Estrogen mediates inflammatory role of mast cells in endometriosis pathophysiology 2022
- Impact of lifestyle and diet on endometriosis: a fresh look to a busy corner 2022
- Pathophysiological aspects of pain syndrome in endometriosis: A review 2022
- Inflammatory MicroRNAs and the Pathophysiology of Endometriosis and Atherosclerosis: Common Pathways and Future Directions Towards Elucidating the Relationship 2022
- Association between gene polymorphisms of IL‐12, IL‐12 receptor and IL‐27 and organ involvement in Iranian endometriosis patients 2022
- Changes in MCP‐1, HGF, and IGF‐1 expression in endometrial stromal cells, PBMCs, and PFMCs of endometriotic women following 1,25(OH)2D3 treatment 2022
- The latest advances in the pharmacological management of endometriosis 2022
- Peritoneal Fluid Leptin Levels in Endometriosis: A Retrospective Cohort Study 2022
Source provenance
- europepmc
- last seen: 2026-06-04T01:30:01.192114+00:00
- openalex
- last seen: 2026-06-04T00:00:01.174412+00:00
- pubmed
- last seen: 2026-05-13T22:13:13.417725+00:00
License: CC0
· commercial use OK